Ovestin 1mg per gram Vaginal cream

*
Pharmacy Only: Prescription
  • Company:

    Aspen
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 02 December 2024

File name

Estr_Crm_IE_P_1mg-g_v9.pdf

Reasons for updating

  • Change to section 6 - date of revision

Updated on 21 November 2023

File name

Estr_Crm_IE_S_1mg-g_v6.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 21 November 2023

File name

Estr_Crm_IE_S_1mg-g_v6.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 21 November 2023

File name

Estr_Crm_IE_P_1mg-g_v8.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Updated on 31 January 2023

File name

Estr_Crm_IE_S_1mg-g_v5.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 05 November 2020

File name

Estr_Crm_IE_S_1mg-g_v5.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 05 November 2020

File name

Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 23 December 2019

File name

Estr_Crm_IE_S_1mg-g_v4.pdf

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 23 December 2019

File name

Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf

Reasons for updating

  • Change to Section 1 - what the product is
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 08 October 2019

File name

Estr_Crm_IE_S_1mg-g_Feb2017_v3.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

File name

Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf

Updated on 18 May 2018

File name

Estr_Crm_IE_P_1mg-g_Apr2018_v5.pdf

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to date of revision

Updated on 14 February 2017

File name

PIL_15975_46.pdf

Reasons for updating

  • New PIL for new product

Updated on 14 February 2017

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 14 March 2016

Reasons for updating

  • Change to date of revision
  • Addition of information on reporting a side effect.
  • Correction of spelling/typing errors

Updated on 31 March 2015

Reasons for updating

  • Change to date of revision
  • Change to name of manufacturer

Updated on 11 April 2014

Reasons for updating

  • New PIL for medicines.ie